AQUIS EXCHANGE PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 465 GBX | -0.85% |
|
+9.67% | +27.40% |
| 24/04 | EDX Medical to begin trading on Apex segment of AQSE next week | AN |
| 23/04 | Marula reaches "significant milestone" for Tanzanian graphite projects | AN |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The firm trades with high earnings multiples: 25.55 times its 2023 earnings per share.
- The company's enterprise value to sales, at 4.72 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Financial & Commodity Market Operators
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +27.40% | 153M | - | ||
| +0.16% | 75.94B | B | ||
| +12.06% | 21.7B | C+ | ||
| +27.19% | 12.54B | C+ | ||
| +39.83% | 8.36B | C+ | ||
| -0.13% | 7.96B | B- | ||
| +44.53% | 5.21B | C | ||
| -2.16% | 2.96B | C+ | ||
| -5.45% | 1.69B | C | ||
| +15.14% | 1.29B | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- AQX Stock
- Ratings Aquis Exchange PLC
